Pharmagen, Inc.
PHRXOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$5171
P/E Ratio—
52W High$0.00001
52W Low$0.000001
Pharmagen, Inc. (PHRX) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · PHRX · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2013-12 |
|---|---|
| Revenue | |
| Revenue | $0.00M |
| Cost of Revenue | $0.00M |
| Gross Profit | $0.00M |
| Gross Margin %(computed) | 63.27% |
| Operating Expenses | |
| R&D Expenses | $0.00M |
| G&A Expenses | $0.00M |
| Total Operating Expenses | $0.01M |
| Operating Income | ($0.00M) |
| Operating Margin %(computed) | -44.86% |
| Interest Income | $0.00M |
| Interest Expense | $3.01M |
| Income Before Tax | ($0.01M) |
| Income Tax Expense | $0.00M |
| Net Income | ($0.01M) |
| Net Margin %(computed) | -134.17% |
| Per Share & EBITDA | |
| EPS (Basic) | $-0.02 |
| Wtd Avg Shares | 0.38M |
| EBITDA | ($2.89M) |
| EBITDA Margin %(computed) | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Pharmagen, Inc. data
About Pharmagen, Inc. (PHRX) Income Statement
Pharmagen, Inc. (PHRX) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2013, PHRX reported revenue of $0.00B, gross profit of $0.00B (gross margin 63.27%), and net income of ($0.00B) — a net profit margin of -134.17%.
Frequently asked questions
PHRX · 4 questionsPharmagen, Inc. (PHRX) reported revenue of $0.00B for 2013, down —% year-over-year.
PHRX revenuePHRX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09